ArticleThe Journal of clinical investigation2026

Human monoclonal antibodies targeting α-Gal restrict IgE engagement of α-Gal syndrome allergens.

Hyeseon Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.